ARAAX
Price
$27.47
Change
+$0.12 (+0.44%)
Updated
Jun 12 closing price
Net Assets
1.57B
FLDFX
Price
$14.56
Change
+$0.05 (+0.34%)
Updated
Jun 12 closing price
Net Assets
487.47M
Interact to see
Advertisement

ARAAX vs FLDFX

Header iconARAAX vs FLDFX Comparison
Open Charts ARAAX vs FLDFXBanner chart's image
ARAAX vs FLDFX Comparison Chart in %
View a ticker or compare two or three
VS
ARAAX vs. FLDFX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAAX is a Buy and FLDFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARAAX has more cash in the bank: 1.57B vs. FLDFX (487M). FLDFX pays higher dividends than ARAAX: FLDFX (0.85) vs ARAAX (0.50). ARAAX was incepted earlier than FLDFX: ARAAX (11 years) vs FLDFX (20 years). FLDFX (1.47) and ARAAX (1.40) have similar cost to investors . FLDFX is a more actively managed with annual turnover of: 243.00 vs. ARAAX (172.00). ARAAX (2500) and FLDFX (2500) have matching initial minimum investment requirements. FLDFX annual gain was more profitable for investors over the last year : 15.48 vs. ARAAX (12.15). FLDFX return over 5 years is better than : 11.97 vs. ARAAX (10.29).
ARAAXFLDFXARAAX / FLDFX
Total Expense Ratio1.401.4795%
Annual Report Gross Expense Ratio1.401.4795%
Fund Existence11 years20 years-
Gain YTD9.8367.699128%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.57B487M322%
Annual Yield % from dividends0.500.8559%
Returns for 1 year12.1515.4878%
Returns for 3 years29.3525.66114%
Returns for 5 years10.2911.9786%
Returns for 10 years55.8357.8796%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMA0.440.01
+1.75%
Mixed Martial Arts Group Limited
CHT46.090.09
+0.20%
CHUNGHWA TELECOM CO Ltd
BFH101.710.08
+0.08%
Bread Financial Holdings
TALK5.21N/A
N/A
Talkspace
ABOS2.37N/A
N/A
Acumen Pharmaceuticals